A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Intervention Adherence Rate
- Status
- Recruiting
- Last Updated
- 3 months ago
Overview
Brief Summary
To learn more about the experiences of adolescent and young adult cancer survivors and investigate whether a group-based writing intervention can help to improve quality of life of adolescent and young adult cancer survivors.
Detailed Description
Primary Objective: To evaluate the feasibility of a virtual, group-based expressive writing intervention for survivors of adolescent and young adult cancer. Secondary Objective: To preliminarily assess the impact of the study for cancer survivors.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 15 - 39 years at cancer diagnosis
- •Age 18 - 39 years at study entry
- •Diagnosed between 1 and 5 years ago prior to enrollment
- •Can speak, read, and write in English
Exclusion Criteria
- •Nonmelanoma skin cancer
- •Major mental health disorder (e.g., schizophrenia or bipolar disorder \[determined from patient records or self-disclosure\])
- •No internet access.
Outcomes
Primary Outcomes
Intervention Adherence Rate
Time Frame: At the end of intervention (week 8)
The intervention adherence rate will be calculated as the number of completed writing tasks divided by the total number of assigned tasks (4).
Study Completion Rate
Time Frame: At 1 month follow-up
The Study completion rate is defined as the average proportion of participants who complete follow-up assessments at 1-month follow-up. We will also calculate the 95% confidence intervals for the study completion rate.
Secondary Outcomes
- Perceived Stress(Baseline, and 1- and 3-month follow-up)
- Common Humanity & Self-Kindness(Baseline, and 1- and 3-month follow-up)
- Coping self-efficacy(Baseline, and 1- and 3-month follow-up)
- Impact of Event Scale(Baseline, and 1- and 3-month follow-up)
- Functional Assessment of Cancer Therapy-General(Baseline, and 1- and 3-month follow-up)
- Posttraumatic growth(Baseline, and 1- and 3-month follow-up)